

(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.


IN BRIEF: NetScientific's PDS Kicks Off Study For PDS0101 Cancer Drug


UK WINNERS & LOSERS SUMMARY: Taylor Wimpey Up On Strong Client Demand


NetScientific Reports Narrowed Annual Loss On Lower Costs


UK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis


LONDON BRIEFING: Whiff Of Covid-19 Cure Sends Pharma Stocks Soaring


NetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine


NetScientific To Invest Further USD650,000 In PDS Biotechnology